Would you offer any adjuvant therapy for a young patient with anal cancer s/p definitive chemoradiation and R0 resection with significant residual disease?

We do not have complete details regarding the clinical history of this case. For instance, information about the patient’s initial response to chemoradiation—whether residual disease was identified early or if this represents a local recurrence after an initial favorable response—would be important ...